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Summary Reproductive factors are known to be aetiologically important in breast cancer, but less is known regarding their effect on breast
cancer prognosis. We have investigated the prognostic effect of age at first birth and total parity using data from the Danish Breast Cancer
Cooperative Group that, since 1977, has collected population-based information on tumour characteristics, treatment regimes and follow-up
status on Danish women with breast cancer. Details of pregnancy history were added from the Danish Civil Registration System and the
National Birth Registry. Included in the study were 10 703 women with primary breast cancer. After adjusting for age and stage of disease
(tumour size, axillary nodal status and histological grading), the number of full-term pregnancies was found without prognostic value.
However, women with primary childbirth between 20 and 29 years experienced a significantly reduced risk of death compared with women
with primary childbirth below the age of 20 years [20-24 years: relative risk (RR) = 0.88, 95% confidence interval (Cl) 0.78-0.99; 25-29 years:
RR = 0.80, 95% Cl 0.70-0.91]. Further adjustment for oestrogen receptor status did not influence these results. The effect was not modified
by age at diagnosis, tumour size or nodal status. In conclusion, low age at first childbirth, but not parity, was associated with a poor prognosis
of breast cancer. We speculate whether women who develop breast cancer despite an early first full-term pregnancy might represent a
selected group with a more malignant disease.
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It is well-established that reproductive factors influence the risk of
breast cancer development (McPherson et al, 1994). Based on
animal studies, it has been hypothesized that pregnancy induces
differentiation and maturation ofthe breast cells and that the cells
subsequently become less vulnerable to carcinogenic stimuli
(Russo et al, 1990). Parous women and in particular multiparous
women are known to be at a lower risk ofbreast cancer than nulli-
parous women. Women having their first childbirth at a young age
seem to experience a particular reduction in risk (MacMahon et al,
1970; Ewertz et al, 1990).
Factors influencing the development ofbreast cancer might also
affect its course, but studies of the prognostic influence of repro-
ductive factors have been contradictory (Papatestas et al, 1980;
Palmer et al, 1982; Black et al, 1983; Wang et al, 1985; Mohle
Boetani et al, 1988; Lees et al, 1989; Mason et al, 1990; Lehrer et
al, 1992; Guinee et al, 1994; Korzeniowski and Dyba, 1994; Off
and Fraher, 1995; von Schoultz et al, 1995; Schouten et al, 1997).
We took advantage of the population-based registration of breast
cancer patients established by the Danish Breast Cancer
Cooperative Group (DBCG) and a database containing complete
information on parity to evaluate the possible importance ofchild-
birth history and age at first birth as prognostic factors in primary
breast cancer.
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MATERIALS AND METHODS
Population registries
Primary clinical and histopathological data together with data
concerning post-operative therapy and follow-up have been regis-
tered by the DBCG since 1977 (Andersen and Mouridsen, 1988).
The Danish Cancer Registry contains information on nearly all
incident cases of malignant neoplasms diagnosed in Denmark
since 1943 (Storm, 1991). The DBCG has information on 93% of
all breast cancer patients born after 1 April 1935, reported to The
Danish Cancer Registry.
The primary surgical treatment of the patients included total
mastectomy plus axillary sampling (90% ofcases), or lumpectomy
with axillary sampling. Patients were hereafter classified as either
low risk or high risk according to histopathological criteria.
Treatment guidelines, strategy for risk group allocation and post-
operative treatment have previously been described in detail
(Andersen and Mouridsen, 1988; Kroman et al, 1994).
Patients with bilateral breast cancer, distant metastases, inflam-
matory cancer, with contraindication to the planned post-operative
therapy, or patients who were not treated according to the surgical
guidelines were not allocated to treatment protocols (miscella-
neous group). The miscellaneous patient group could be separated
into a group with a favourable prognosis and a group with a bad
prognosis. Patients who were excluded from protocol allocation
because of a surgical treatment that did not follow the guidelines
had a better prognosis than patients excluded for other reasons.
Information on reproductive history was obtained by linkage
with the Civil Registration System (CRS). The CRS was estab-
lished on 1 April 1968 when all residents in Denmark were regis-
tered and assigned a unique identification number that permits
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Table 1 Distribution of 10 703 women with primary breast cancer born after 1 April 1935, diagnosed during 1978-94 according to age at diagnosis, tumour
characteristics, protocol allocation, parity, and age at first childbirth
Age at first birth
No. (%)
Nulliparous <20 years 20-24 years 25-29 years .30 years
Total no. 1260 1468 4416 2670 889
Age at diagnosis
<35 years 138 (11.0) 71 (4.8) 225 (5.1) 184 (6.9) 31 (3.5)
35-39 years 169 (13.4) 211 (14.4) 595 (13.5) 374 (14.0) 122 (13.7)
40-44 years 318 (25.2) 434 (29.6) 1128 (25.5) 701 (26.3) 258 (29.0)
45-49 years 337 (26.8) 452 (30.8) 1392 (31.5) 781 (29.3) 273 (30.7)
.50 years 298 (23.7) 300 (20.4) 1076 (24.4) 630 (23.6) 205 (23.1)
Tumour size
<2cm 576 (45.7) 837 (57.0) 2446 (55.4) 1429 (53.5) 461 (51.9)
>2, <5 cm 480 (38.1) 457 (31.1) 1477 (33.5) 936 (35.1) 300 (33.7)
>5cm 119 (9.4) 87 (5.9) 261 (5.9) 158 (5.9) 76 (8.5)
No information 85 (6.8) 87 (5.9) 232 (5.3) 147 (5.5) 52 (5.8)
Positive nodes
0 600 (47.6) 784 (53.4) 2301 (52.1) 1359 (50.9) 448 (50.4)
1-3 374 (29.7) 401 (27.3) 1204 (27.3) 777 (29.1) 237 (26.7)
4-9 152 (12.1) 160 (10.9) 538 (12.2) 307 (11.5) 127 (14.3)
.10 49 (3.9) 48 (3.3) 165 (3.7) 110 (4.1) 39 (4.4)
No information 85 (6.8) 75 (5.1) 208 (4.7) 117 (4.4) 38 (4.3)
Histological grading
302 (24.0) 362 (24.7) 1135 (25.7) 668 (25.0) 210 (23.6)
11 + III 664 (52.7) 802 (54.6) 2268 (51.4) 1353 (50.7) 471 (53.0)
NDa 294 (23.3) 304 (20.7) 1013 (22.9) 649 (24.3) 208 (23.4)
Protocol allocation
Yes 980 (77.8) 1234 (84.1) 3748 (84.9) 2245 (84.1) 740 (83.2)
No
Not treated according
to surgical guidelines 158 (12.5) 168 (11.4) 457 (10.4) 291 (10.9) 101 (11.4)
Not allocated because 122 (9.7) 66 (4.5) 211 (4.8) 134 (5.0) 48 (5.4)
of other reasonsb
Parity
1 157 (10.7) 586 (13.3) 648 (24.3) 489 (55.0)
2 639 (43.5) 2325 (52.7) 1555 (58.2) 350 (39.4)
3 471 (32.1) 1199 (27.2) 399 (14.9) 42 (4.7)
.4 201 (13.7) 306 (6.9) 68 (2.6) 8 (0.9)
alncluding patients with non-ductal carcinomas (n = 2089, 84.6%) and patients without information on histological grading (n = 379, 15.4%). bMedical
contraindications, bilateral breast cancer, distant metastasis, or inflamatory cancer.
identity secure linkage of information between registries. Parents
were recorded with a link to most of their children born in the
beginning of the 1950s or later and alive in 1968. Since then, the
CRS registry has kept updated files on dates on all live births and
residents in Denmark including updated files on vital status. A
more detaileddescription ofthe reproductive information included
in this registry is given elsewhere (Melbye et al, 1997).
Information on stillbirths was available during the period 1978-93
from the National Birth Registry.
Subjects
Permission was obtained in advance from the National Scientific
Ethics Committee and the Data Protection Board to link informa-
tion on patients in the DBCG registry with the CRS registry and
the National Birth Registry. Women born before 1935 have no
systematic link to all their children in the CRS registry. Therefore,
we restricted our study group to women born since 1 April 1935.
All women with a diagnosis of breast cancer before 1 October
1994 were included and followed until 1 October 1995, with
respect to vital status.
Statistical analysis
The associations between the study variables and survival were
investigated using the Cox Proportional Hazards method (Cox,
1972). Multivariate analyses included tumour size (<2 cm, >2 and
up to 5 cm, >5 cm), positive lymph nodes (0, 1-3, 4-9, .10),
histological grading (I, II and III, non-ductal patients and those
without information on histological grading), age at first birth
(nulliparous, <20, 20-24, 25-29, .30 years), parity atdiagnosis (0,
1, 2, 3, .4), age at diagnosis (<35, 35-39, 40-44, 45-49, .50
years), year of diagnosis, and protocol allocation (see Table 1).
The adequacy of the proportional hazard assumptions for the
included variables was checked by log(- logS) plots from strati-
fied multivariate analyses. For both tumour size and lymph node
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Table 2 Adjusted relative risk (aRR) of dying according to prognostic
factors, protocol allocation and parity in 10 703 breast cancer patients born
after 1 April 1935 and diagnosed 1978-94
Variables aRR (95% Cl)y
Tumour size
>2 cm 1 (reference)
>2, <5 cm 1.63 (1.49-1.78)b
> 5 cm 2.17 (1.90 2.49)b
Positive nodes
0 1 (reference)
1-3 1.71 (1.53-1.91)b
4-9 3.32 (2.97-3.72)b
>10 4.72 (4.02-5.52)b
Histological grading
1 (reference)
11 + III 2.33 (2.07-2.62)b
NDc 1.18 (1.02-1.36)b
Protocol allocation
Allocated patients 1 (reference)
Not treated according to guidelines 1.04 (0.91-1.17)
Not allocated because of other reasonsd 2.76 (2.43-3.13)b
Parity
Nulliparous 1 (reference)
Parous 0.95 (0.85-1.06)
aAdjusted relative risk (95% confidence intervals) adjusted for all
characteristics listed above and age at diagnosis and year of diagnosis.
bp<0.05. cPatients with non-ductal carcinomas and patients without
information on histological grading. dMedical contraindications, bilateral
breast cancer, distant metastasis, or inflamatory cancer.
status, the hazard rate of the heterogeneous category of missing
information was not proportional to the hazard rates of the other
categories. Therefore, the Cox regression was performed in four
strata (information on tumour size and lymph node status avail-
able, only tumour size missing, only lymph node status missing,
both missing). The estimates were only slightly changed ifwomen
with missing tumour size or nodal status were excluded from the
analysis. Tests for effect modification were performed as tests for
interaction between categorized variables. In an exploratory
analysis, we categorized year of treatment in 1-year intervals, but
this did not affect the results - a finding that argues against
residual confounding. All analyses were performed using likeli-
hood ratio tests by means of the SAS procedure PROC PHREG
(SAS Institute, 1992).
RESULTS
By 1 October 1994, 10 803 women with primary breast cancer
born after 1 April 1935 were registered in the DBCG. One hundred
patients were excluded because of delivery after diagnosis. Of the
remaining 10 703 patients, 1260 (11.8%) were nulliparous and
9443 patients (88.2%) were parous. The follow-up time ranged
from 13 months to 17 years representing a total of 60 322
person-years of follow-up. Distribution of patients according to
age at diagnosis, tumour characteristics, protocol allocation, parity
and age at first birth is given in Table 1.
The influence of these factors on breast cancer prognosis was
evaluated in a multivariate analysis. The relative risk of dying
according to tumour characteristics and status as nulliparous or
parous is given in Table 2. Table 3 shows the relative risk ofdying
Table 3 Adjusted relative risk (aRR) of dying according to number of full-
term pregnancies, and age at first childbirth in 9443 parous breast cancer
patients born after 1 April 1935 and diagnosed 1978-94
Variables aRR (95% CI)a aRR (95% CI)b
Parity
Nulliparous 1.04 (0.90-1.19)
1 1 (reference) 1 (reference)
2 0.96 (0.86-1.07) 0.97 (0.86-1.08)
3 0.99 (0.88-1.12) 0.98 (0.85-1.11)
>4 1.07 (0.90-1.28) 1.04 (0.87-1.25)
Age at first birth
Nulliparous 0.92 (0.80-1.06)
<20 years 1 (reference) 1 (reference)
20-24 years 0.87 (0.78-0.98)c 0.88 (0.78-0.99)c
25-29 years 0.79 (0.70-0.90)c 0.80 (0.70-0.91)c
>30 years 0.94 (0.80-1.11) 0.94 (0.79-1.12)
aAdjusted relative risk (95% confidence intervals) adjusted for age at
diagnosis, tumour size, nodal status histological grading, protocol allocation,
and year of diagnosis. bAdjusted relative risk further adjusted for parity
factors listed above. cp < 0.05.
Table 4 Stratified analysis of risk of dying according to age at diagnosis,
nodal status, tumour size, and age at first childbirth among 9443 parous
breast cancer patients
Age at first birth
<20 years 20-24 years 25-29 years >30 years
aRRa aRRa aRRa aRRa
Age at diagnosis
<35 years 1 (reference) 1.6 (0.99-2.5) 1.2 (0.8-2.0) 2.0 (0.96-4.1)
35-39 years 1 (reference) 0.9 (0.7-1.1) 0.9 (0.7-1.2) 1.1 (0.8-1.6)
40-44 years 1 (reference) 0.7 (0.6-0.9)b 0.7 (0.6-0.9)b 0.8 (0.6-1.0)
45-49 years 1 (reference) 0.8 (0.6-1.0) 0.7 (0.6-0.9)b 0.9 (0.7-1.2)
.50 years 1 (reference) 1.1 (0.8-1.5) 0.9 (0.6-1.3) 1.0 (0.6-1.5)
Tumour size
<2 cm 1 (reference) 0.8 (0.60.9)b 0.8 (0.6-0.9)b 0.9 (0.7-1.2)
>2cm 1 (reference) 0.9 (0.7-1.0) 0.8 (0.7-0.9)b 0.9 (0.7-1.1)
Nodal status
Negative 1 (reference) 0.8 (0.7-1.0) 0.8 (0.6-0.97)b 1.0 (0.7-1.3)
Positive 1 (reference) 0.9 (0.8-1.0) 0.8 (0.7-0.9)b 0.9 (0.8-1.1)
aAdjusted relative risk (95% confidence intervals) adjusted for age at
diagnosis, tumour size, nodal status, histological grading, protocol allocation,
and year of diagnosis. bp < 0.05.
according to parity and age at first childbirth in parous women.
Parous women were found to have a minor insignificantly reduced
risk ofdying compared with nulliparous women [relative risk (RR)
0.95; 95% confidence interval (CI) 0.86-1.06]. The prognosis was
unaffected by the number of children in the group of parous
women (P = 0.78, Table 3).
The adjusted relative risk of dying varied significantly
according to age at first birth as shown in Table 3 (P = 0.005).
Women having their first child at the age of 25-29 years had the
best prognosis. The relative risk of dying was significantly
reduced for women having their first child between the ages of 20
and 24 years (RR 0.88; 95% CI 0.78-0.99) and women with
primary childbirth between the ages of 25 and 29 years (RR 0.80;
95% CI 0.70-0.91) compared with women having primary child-
birth below the age of 20 years (reference group).
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To investigate whether the prognostic effect of age at first birth
was modified by age at diagnosis, extent of disease (measured by
number ofpositiveaxillarylymphnodes) or tumoursize, we tested
for effect modification with adjustment for all other considered
factors as given above (Table 4). Neither tumour size (P = 0.63)
nor nodal status (P = 0.74) had a significantly modifying effect on
the prognostic influence of age at first birth. There was a trend
towards the prognostic effect of age at first childbirth being more
pronounced among women diagnosed between the ages of 40 and
50 years. However, this finding was not significant (P = 0.27).
Oestrogen receptor (ER) status was available on 6016 patients.
Sixty-nine per cent were classified as ER positive and 31% were
classified as ER negative. The negative prognostic effect of age at
first childbirth was not affected by ER status.
DISCUSSION
We found strong evidence that young age ofthe mother at first birth
is associated with poor survival of breast cancer, despite its protec-
tive effect on breast cancer development. Although some studies
have not supported this observation (Mohle Boetani et al, 1988;
Lees et al, 1989; Ewertz etal, 1991),there is accumulating evidence
that does support it (Greenberg et al, 1985; Kogevinas, 1990;
Schouten etal, 1997). A limitation ofprevious studies has been their
small sample sizes (range 582-1744 subjects) compared with the
present study. Furthermore, these studies have primarily been based
on retrospectively collected information obtained among cases and
controls through interviews. The present population-based study
was based on prospectively collected data, with detailed exposure
and outcome information that limits possibilities for recall bias.
Previous reports have shown the risk of developing breast
cancer to be reduced among women who have their first child at an
early age (MacMahon et al, 1970; Ewertz et al, 1990). Based on a
large cohort of 1.5 million women andincluding more than 10000
breast cancer cases, we have similarly found a strongly increasing
risk of breast cancer with increasing age at first childbirth (J
Wohlfahrt, PK Anderson, HT Mouridsen, HO Adami and M
Melbye personal communication). Thus, one could argue that
some women who avoided breast cancer because of a delivery at
an early age would have developed breast cancer ifthey had had
their first childbirth late or ifthey had remained nulliparous. These
women who avoided breast cancers might be those with the most
favourable course. Following this argument, the observed reduced
survival in breast cancer patients with early first childbirth might
reflect a selection of more aggressive cases rather than a direct
biological effect of the early pregnancy on the carcinogenic
process. We acknowledge that women with an early first childbirth
did not have a poorer profile of the available prognostic factors.
However, these prognostic factors do not necessarily offer a
complete picture of thebiological behaviour of the tumours.
There was a suggestion, although not statistically significant,
that early first childbirth is a negative prognostic factor of breast
cancer in older premenopausal women aged 40-49 years. The
assumption that the negative effect of early first childbirth is a
consequence of a selection is supported by epidemiological data
showing that the protective effect ofearly first childbirth on breast
cancer development is most pronounced in older premenopausal
women (Ewertz et al, 1990).
In the Western world, the median age of first childbirth has
increased over the past decades. It is generally accepted that this
postponement of motherhood has contributed to the rising inci-
dence of breast cancer. Our study suggests that the postponement
of motherhood might have a beneficial effect on overall breast
cancer prognosis.
Studies on overall parity as a prognostic factor have been
contradictory (von Papatestas et al, 1980; Palmer et al, 1982;
Black et al, 1983; Wang et al, 1985; Mohle-Boetani et al, 1988;
Lees et al, 1989; Mason et al, 1990; Lehrer et al, 1992; Guinee et
al, 1994; Korzeniowski and Dyba, 1994; Orr and Fraher, 1995;
Schoultz et al, 1995). We have previously found that pregnancy
within 2 years before a diagnosis of breast cancer was associated
with reduced survival (Kroman et al, 1997). This, combined with
the present observation of early first childbirth being a negative
prognostic factor, could explain the finding reported by some
researchers of an association between high parity and poor prog-
noses (Wang et al, 1985; Lees et al, 1989; Korzeniowski and
Dyba, 1994). Women with high parity would be expected to have
their first child early and have their last child late. Therefore,
women with high parity would be over-represented in the two
high-risk groups defined by us. In the present study, high parity
alone did not serve as an independent prognostic factor.
The observation that breast cancer may be a high social status
disease has been related to differences in childbirth patterns
(Kelsey and Horn Ross, 1993). In contrast, several studies have
shown that low social class is associated with reduced survival
(Karjalainen and Pukkala, 1990; Kogevinas et al, 1991; Gordon et
al, 1992). It may be of relevance for the latter finding that poorly
educated women tend to have their first child earlier than women
with higher education level (Knudsen, 1993).
In conclusion, we found that age at first birth is a prognostic
factor in breast cancer, whereas parity did not affect the survival.
These findings may provide further insight into breast tumour
pathogenesis and should be considered in future evaluations of
other prognostic factors ofimportance for this disease.
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